Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jessica Haberer, M.D.

Co-Author

This page shows the publications co-authored by Jessica Haberer and Alexander Tsai.
Connection Strength

3.306
  1. High Rates of Biomarker-Confirmed Alcohol Use Among Pregnant Women Living With HIV in South Africa and Uganda. . 2019 12 15; 82(5):443-451.
    View in: PubMed
    Score: 0.443
  2. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa. J Int AIDS Soc. 2019 02; 22(2):e25232.
    View in: PubMed
    Score: 0.209
  3. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017 Mar 22; 20(1):1-15.
    View in: PubMed
    Score: 0.183
  4. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations. J Int AIDS Soc. 2017; 20(1):21371.
    View in: PubMed
    Score: 0.183
  5. Real-time electronic adherence monitoring plus follow-up improves adherence compared with standard electronic adherence monitoring. AIDS. 2017 01 02; 31(1):169-171.
    View in: PubMed
    Score: 0.181
  6. Explaining antiretroviral therapy adherence success among HIV-infected children in rural Uganda: a qualitative study. AIDS Behav. 2015 Apr; 19(4):584-93.
    View in: PubMed
    Score: 0.160
  7. Persistent HIV-related stigma in rural Uganda during a period of increasing HIV incidence despite treatment expansion. AIDS. 2015 Jan 02; 29(1):83-90.
    View in: PubMed
    Score: 0.157
  8. Declining prevalence of probable depression among patients presenting for antiretroviral therapy in rural Uganda: the role of early treatment initiation. AIDS Behav. 2015 Jan; 19(1):19-26.
    View in: PubMed
    Score: 0.157
  9. The dynamic relationship between social support and HIV-related stigma in rural Uganda. Ann Behav Med. 2014 Aug; 48(1):26-37.
    View in: PubMed
    Score: 0.153
  10. CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda. AIDS. 2014 May 15; 28(8):1221-6.
    View in: PubMed
    Score: 0.150
  11. Internalized stigma, social distance, and disclosure of HIV seropositivity in rural Uganda. Ann Behav Med. 2013 Dec; 46(3):285-94.
    View in: PubMed
    Score: 0.146
  12. How does antiretroviral treatment attenuate the stigma of HIV? Evidence from a cohort study in rural Uganda. AIDS Behav. 2013 Oct; 17(8):2725-31.
    View in: PubMed
    Score: 0.144
  13. Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa. AIDS Behav. 2020 Sep; 24(9):2624-2636.
    View in: PubMed
    Score: 0.116
  14. Biomarker-Measured Unhealthy Alcohol Use in Relation to CD4 Count Among Individuals Starting ART in Sub-Saharan Africa. AIDS Behav. 2019 Jun; 23(6):1656-1667.
    View in: PubMed
    Score: 0.107
  15. Treated HIV Infection and Progression of Carotid Atherosclerosis in Rural Uganda: A Prospective Observational Cohort Study. J Am Heart Assoc. 2021 Jun 15; 10(12):e019994.
    View in: PubMed
    Score: 0.061
  16. Adherence to HIV antiretroviral therapy among pregnant and postpartum women during the Option B+ era: 12-month cohort study in urban South Africa and rural Uganda. J Int AIDS Soc. 2020 08; 23(8):e25586.
    View in: PubMed
    Score: 0.058
  17. Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda. AIDS. 2019 11 01; 33(13):2043-2048.
    View in: PubMed
    Score: 0.055
  18. Timing of Antiretroviral Therapy and Systemic Inflammation in Sub-Saharan Africa: Results From the META Longitudinal Cohort Study. J Infect Dis. 2019 08 30; 220(7):1172-1177.
    View in: PubMed
    Score: 0.054
  19. CYP2B6 Genetic Polymorphisms, Depression, and Viral Suppression in Adults Living with HIV Initiating Efavirenz-Containing Antiretroviral Therapy Regimens in Uganda: Pooled Analysis of Two Prospective Studies. AIDS Res Hum Retroviruses. 2018 11; 34(11):982-992.
    View in: PubMed
    Score: 0.050
  20. Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda. J Acquir Immune Defic Syndr. 2018 08 01; 78(4):458-464.
    View in: PubMed
    Score: 0.050
  21. Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study. Ann Intern Med. 2018 08 07; 169(3):146-155.
    View in: PubMed
    Score: 0.050
  22. HIV infection and arterial stiffness among older-adults taking antiretroviral therapy in rural Uganda. AIDS. 2016 Feb 20; 30(4):667-70.
    View in: PubMed
    Score: 0.043
  23. The factor structure and presentation of depression among HIV-positive adults in Uganda. AIDS Behav. 2015 Jan; 19(1):27-33.
    View in: PubMed
    Score: 0.039
  24. Depression during pregnancy and the postpartum among HIV-infected women on antiretroviral therapy in Uganda. . 2014 Dec 01; 67 Suppl 4:S179-87.
    View in: PubMed
    Score: 0.039
  25. Empiric deworming and CD4 count recovery in HIV-infected Ugandans initiating antiretroviral therapy. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3036.
    View in: PubMed
    Score: 0.038
  26. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. . 2014 Apr 01; 65(4):456-62.
    View in: PubMed
    Score: 0.037
  27. Treatment as long-term prevention: sustained reduction in HIV sexual transmission risk with use of antiretroviral therapy in rural Uganda. AIDS. 2014 Jan 14; 28(2):267-71.
    View in: PubMed
    Score: 0.037
  28. GPS-measured distance to clinic, but not self-reported transportation factors, are associated with missed HIV clinic visits in rural Uganda. AIDS. 2013 Jun 01; 27(9):1503-8.
    View in: PubMed
    Score: 0.035
  29. Dissemination of research findings to research participants living with HIV in rural Uganda: challenges and rewards. PLoS Med. 2013; 10(3):e1001397.
    View in: PubMed
    Score: 0.035
  30. Higher baseline CD4 cell count predicts treatment interruptions and persistent viremia in patients initiating ARVs in rural Uganda. . 2013 Mar 01; 62(3):317-21.
    View in: PubMed
    Score: 0.035
  31. No association found between traditional healer use and delayed antiretroviral initiation in rural Uganda. AIDS Behav. 2013 Jan; 17(1):260-5.
    View in: PubMed
    Score: 0.034
  32. Sexual relationship power and malnutrition among HIV-positive women in rural Uganda. AIDS Behav. 2012 Aug; 16(6):1542-8.
    View in: PubMed
    Score: 0.033
  33. Rethinking the "pre" in pre-therapy counseling: no benefit of additional visits prior to therapy on adherence or viremia in Ugandans initiating ARVs. PLoS One. 2012; 7(6):e39894.
    View in: PubMed
    Score: 0.033
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.